Ipca Laboratories has reported results for third quarter ended December 31, 2015.
The company has reported 44.18% fall in its net profit at Rs 23.18 crore for the quarter ended December 31, 2015 as compared to Rs 41.53 crore for the same quarter in the previous year. The company’s total income has decreased by 7.77% to Rs 689.07 crore for the quarter under review from Rs 747.09 crore for the corresponding quarter of the previous year.
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.
